HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparative leprosy vaccine trial in south India.

Abstract
This report provides results from a controlled, double blind, randomized, prophylactic leprosy vaccine trial conducted in South India. Four vaccines, viz BCG, BCG+ killed M. leprae, M.w and ICRC were studied in this trial in comparison with normal saline placebo. From about 3,00,000 people, 2,16,000 were found eligible for vaccination and among them, 1,71,400 volunteered to participate in the study. Intake for the study was completed in two and a half years from January 1991. There was no instance of serious toxicity or side effects subsequent to vaccination for which premature decoding was required. All the vaccine candidates were safe for human use. Decoding was done after the completion of the second resurvey in December 1998. Results for vaccine efficacy are based on examination of more than 70% of the original "vaccinated" cohort population, in both the first and the second resurveys. It was possible to assess the overall protective efficacy of the candidate vaccines against leprosy as such. Observed incidence rates were not sufficiently high to ascertain the protective efficacy of the candidate vaccines against progressive and serious forms of leprosy. BCG+ killed M. leprae provided 64% protection (CI 50.4-73.9), ICRC provided 65.5% protection (CI 48.0-77.0), M.w gave 25.7% protection (CI 1.9-43.8) and BCG gave 34.1% protection (CI 13.5-49.8). Protection observed with the ICRC vaccine and the combination vaccine (BCG+ killed M. leprae) meets the requirement of public health utility and these vaccines deserve further consideration for their ultimate applicability in leprosy prevention.
AuthorsM D Gupte, R S Vallishayee, D S Anantharaman, B Nagaraju, Sreevatsa, S Balasubramanyam, R L de Britto, N Elango, N Uthayakumaran, V N Mahalingam, G Lourdusamy, A Ramalingam, S Kannan, J Arokiasamy
JournalIndian journal of leprosy (Indian J Lepr) 1998 Oct-Dec Vol. 70 Issue 4 Pg. 369-88 ISSN: 0254-9395 [Print] India
PMID10189587 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • BCG Vaccine
  • Vaccines, Inactivated
Topics
  • Adolescent
  • Adult
  • Aged
  • BCG Vaccine
  • Child
  • Child, Preschool
  • Double-Blind Method
  • Drug Evaluation
  • Female
  • Humans
  • India
  • Infant
  • Leprosy (prevention & control)
  • Male
  • Middle Aged
  • Mycobacterium leprae
  • Vaccines, Inactivated

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: